tyrosine has been researched along with Movement Disorders in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (44.44) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Balasubramaniam, S; Bandodkar, S; Devanapalli, B; Junek, R; Kim, WT; Mohammad, S; Parayil Sankaran, B; Wong, RSH; Wotton, T | 1 |
| Beckett, TL; Keller, JN; Niedowicz, DM; Paul Murphy, M; Studzinski, CM | 1 |
| Buchfelder, M; Doelken, M; Ganslandt, O; Kuwert, T; Linke, R; Nimsky, C; Pölking, E; Prante, O; Stadlbauer, A | 1 |
| Bramanti, P; Crisafulli, C; Cuzzocrea, S; Di Paola, R; Galuppo, M; Genovese, T; Mazzon, E; Paterniti, I | 1 |
| Homma, D; Ichinose, H; Ikemoto, K; Katoh, S; Kondo, K; Nomura, T; Sumi-Ichinose, C; Tokuoka, H | 1 |
| Aubert, A; Barberger-Gateau, P; Capuron, L; Féart, C; Fuchs, D; Higueret, D; Layé, S; Schroecksnadel, S | 1 |
| Bhatia, KP; Burke, D; Carecchio, M; Chandrashekar, HS; Edwards, MJ; Footitt, EJ; Kojovic, M; Lachmann, RH; Murphy, E; Parees, I; Rubio-Agusti, I | 1 |
| Forsyth, RJ; Gika, AD; Ginjaar, I; Tijssen, MA | 1 |
| Bennett, JP; Schuh, LA | 1 |
| Abeles, I; Covault, J; Deckel, AW; Gary, KA; Sasso, D; Schmerler, N; Volmer, P; Watts, D; Weiner, R; Yan, Z | 1 |
| Costall, B; Naylor, RJ | 1 |
| Cotzias, GC; Gellene, R; Papavasiliou, PS | 1 |
| Birkmayer, W | 1 |
| Constantinidis, J | 1 |
| Gordon, RJ; McKenzie, GM; Viik, K | 1 |
| Barbeau, A | 1 |
| Bédard, P; Larochelle, L; Poirier, LJ | 1 |
| Duffy, KM; Ericsson, AD; Wertman, BG | 1 |
1 review(s) available for tyrosine and Movement Disorders
| Article | Year |
|---|---|
Dopamine and dopamine metabolites in Parkinson's disease-a review.
Topics: Brain Chemistry; Dopamine; Humans; Movement Disorders; Parkinson Disease; Phenylacetates; Tryptophan; Tyrosine | 1968 |
1 trial(s) available for tyrosine and Movement Disorders
| Article | Year |
|---|---|
Modification of Parkinsonism--chronic treatment with L-dopa.
Topics: Adult; Aged; Agranulocytosis; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Urea Nitrogen; Blood-Brain Barrier; Chronic Disease; Dihydroxyphenylalanine; Dopamine; Feeding and Eating Disorders; Female; Humans; Huntington Disease; Male; Manganese; Mental Processes; Methyldopa; Middle Aged; Movement Disorders; Nausea; Neurologic Manifestations; Parkinson Disease; Phenylacetates; Placebos; Thyroid Function Tests; Tyrosine; Vomiting | 1969 |
16 other study(ies) available for tyrosine and Movement Disorders
| Article | Year |
|---|---|
Developmental delay and non-phenylketonuria (PKU) hyperphenylalaninemia in DNAJC12 deficiency: Case and approach.
Topics: Autism Spectrum Disorder; Biopterins; Homovanillic Acid; Humans; Infant, Newborn; Male; Movement Disorders; Neurotransmitter Agents; Phenylalanine; Phenylketonurias; Tyrosine | 2023 |
A ketogenic diet improves motor performance but does not affect β-amyloid levels in a mouse model of Alzheimer's disease.
Topics: Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Diet, Ketogenic; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Movement Disorders; Muscle, Skeletal; Presenilin-1; Reaction Time; Tyrosine | 2013 |
Detection of tumour invasion into the pyramidal tract in glioma patients with sensorimotor deficits by correlation of (18)F-fluoroethyl-L: -tyrosine PET and magnetic resonance diffusion tensor imaging.
Topics: Adult; Aged; Brain; Brain Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Glioma; Humans; Male; Middle Aged; Movement Disorders; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Pyramidal Tracts; Radiography; Sensation Disorders; Sensitivity and Specificity; Tyrosine | 2009 |
Liver X receptor agonist treatment regulates inflammatory response after spinal cord trauma.
Topics: Animals; Anti-Inflammatory Agents; bcl-2-Associated X Protein; Cytokines; Disease Models, Animal; Fas Ligand Protein; Hydrocarbons, Fluorinated; In Situ Nick-End Labeling; Laminectomy; Lipid Peroxidation; Liver X Receptors; Male; Mice; Movement Disorders; Myelitis; Neutrophil Infiltration; NF-kappa B; Nitric Oxide Synthase Type II; Orphan Nuclear Receptors; Peroxidase; Poly Adenosine Diphosphate Ribose; Proteins; Proto-Oncogene Proteins c-bcl-2; Spinal Cord Injuries; Statistics, Nonparametric; Sulfonamides; Time Factors; Tyrosine | 2010 |
Partial biopterin deficiency disturbs postnatal development of the dopaminergic system in the brain.
Topics: Alcohol Oxidoreductases; Animals; Biopterins; Corpus Striatum; Dopamine; Gene Expression Regulation, Developmental; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Neurologic Mutants; Movement Disorders; Phenylalanine; Phenylketonurias; Phosphorus-Oxygen Lyases; Substantia Nigra; Tyrosine; Tyrosine 3-Monooxygenase | 2011 |
Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Fasting; Fatigue; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation; Interleukin-6; Male; Mental Disorders; Movement Disorders; Neopterin; Nitrites; Psychiatric Status Rating Scales; Sleep Wake Disorders; Tryptophan; Tyrosine | 2011 |
Movement disorders in adult patients with classical galactosemia.
Topics: Adult; Anti-Dyskinesia Agents; Benzamides; Botulinum Toxins; Brain; Cross-Sectional Studies; Databases, Factual; Female; Galactosemias; Humans; Magnetic Resonance Imaging; Male; Movement Disorders; Muscarinic Antagonists; Retrospective Studies; Severity of Illness Index; Trihexyphenidyl; Tyrosine; Young Adult | 2013 |
A novel GLRA1 mutation in a recessive hyperekplexia pedigree.
Topics: Child; Child, Preschool; Cysteine; DNA Mutational Analysis; Female; Humans; Movement Disorders; Mutation; Pedigree; Receptors, Glycine; Reflex, Startle; Tyrosine | 2007 |
Suppression of dyskinesias in advanced Parkinson's disease. I. Continuous intravenous levodopa shifts dose response for production of dyskinesias but not for relief of parkinsonism in patients with advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Tyrosine | 1993 |
Dietary arginine alters time of symptom onset in Huntington's disease transgenic mice.
Topics: Animals; Arginine; Blood Glucose; Brain; Cerebrovascular Circulation; Diet; Huntington Disease; Mice; Mice, Transgenic; Movement Disorders; Time Factors; Tyrosine; Weight Loss | 2000 |
Actions of dopaminergic agonists on motor function.
Topics: Amantadine; Animals; Apomorphine; Behavior; Dextroamphetamine; Disease Models, Animal; Dopamine Antagonists; Humans; Hyperkinesis; Levodopa; Methylphenidate; Motor Activity; Movement Disorders; Phenethylamines; Piribedil; Rats; Stereotyped Behavior; Tyrosine | 1975 |
[Experimental findings and new aspects in extrapyramidal diseases].
Topics: 5-Hydroxytryptophan; Blood Pressure; Body Temperature Regulation; Chorea; Dihydroxyphenylalanine; Dopamine; Humans; Monoamine Oxidase Inhibitors; Movement Disorders; Norepinephrine; Parkinson Disease; Perphenazine; Phenylalanine; Reserpine; Serotonin; Tyrosine | 1966 |
[Monoamines and choreic syndromes].
Topics: Amines; Butyrophenones; Chorea; Diazepam; Dihydroxyphenylalanine; Dopamine; Ganglia; Globus Pallidus; Homovanillic Acid; Humans; Huntington Disease; Mental Disorders; Methyldopa; Methyltyrosines; Models, Neurological; Movement Disorders; Phenothiazines; Physostigmine; Reserpine; Thalamus; Tranquilizing Agents; Tyrosine | 1972 |
Some biochemical and behavioural correlates of a possible animal model of human hyperkinetic syndromes.
Topics: Amphetamine; Animals; Atropine; Behavior, Animal; Catecholamines; Cats; Caudate Nucleus; Chlorpromazine; Cholinesterase Inhibitors; Chromatography, Thin Layer; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Electric Stimulation; Ganglionic Blockers; Movement Disorders; Phenylacetates; Picrotoxin; Rats; Tranquilizing Agents; Tritium; Tubocurarine; Tyrosine | 1972 |
[Motor and psychomotor activity of striatal monoamines].
Topics: Animals; Basal Ganglia; Catecholamines; Depression, Chemical; Dihydroxyphenylalanine; Dopamine; Globus Pallidus; Haplorhini; Monoamine Oxidase; Motor Neurons; Movement Disorders; Norepinephrine; Parkinson Disease; Serotonin; Tyrosine | 1970 |
Reversal of the reserpine syndrome with L-dopa metabolites in reserpinized rats.
Topics: Animals; Central Nervous System; Dihydroxyphenylalanine; Motor Skills; Movement Disorders; Normetanephrine; Rats; Reserpine; Tyrosine | 1971 |